• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

疥疮:诊断与治疗的最新进展。

Scabies: Diagnostic and Therapeutic Update.

作者信息

Richards Robert N

机构信息

8613 Departments of Medicine, North York General Hospital and Baycrest Health Sciences, Courtesy Staff Dermatology, Toronto, ON, Canada.

出版信息

J Cutan Med Surg. 2021 Jan-Feb;25(1):95-101. doi: 10.1177/1203475420960446. Epub 2020 Sep 30.

DOI:10.1177/1203475420960446
PMID:32998532
Abstract

BACKGROUND

Scabies is globally ubiquitous and is a significant health issue for institutions, the economically disenfranchised, resource-poor areas, and for those with weakened immune systems. Topicals are usually effective, but are cumbersome and expensive to use in large populations and for those nonadherent to topicals. Oral ivermectin became available in Canada for the off-label treatment of scabies in the fall 2018.

OBJECTIVES

To review the diagnosis and management of scabies. Dose schedules and concomitant management measures are outlined for scabies simplex and for crusted scabies. Ivermectin use is outlined.

METHODS

Medline, colleague discussions, practice review, and experience from managing scabies in institutions.

RESULTS

Oral ivermectin is safe, easier to use, cheaper, more effective, and more economical than topicals in widespread institutional scabies, for those nonadherent to topicals, and in crusted scabies.

CONCLUSIONS

Oral ivermectin is the treatment of choice in large populations, the nonadherent, and for crusted scabies. Oral ivermectin is produced by Merck Canada as Stromectol 3 mg. The treatment dose for noncrusted scabies is 200 µg/kg, taken in a single dose with food. For example, 15 mg (5 tablets) for a 70 kg person. Retreat in 10-14 days to enhance effectiveness, and perhaps to reduce scabicide resistance.

摘要

背景

疥疮在全球普遍存在,对于机构、经济上处于不利地位的人群、资源匮乏地区以及免疫系统较弱的人群而言,是一个重大的健康问题。局部用药通常有效,但在大量人群中使用以及对于那些不坚持使用局部用药的人来说,使用起来繁琐且昂贵。口服伊维菌素于2018年秋季在加拿大可用于疥疮的非标签治疗。

目的

综述疥疮的诊断和管理。概述了单纯性疥疮和结痂性疥疮的剂量方案及伴随的管理措施。概述了伊维菌素的使用。

方法

检索医学期刊数据库、与同事讨论、回顾实践以及总结在机构中管理疥疮的经验。

结果

在广泛的机构性疥疮、对于不坚持使用局部用药的人以及结痂性疥疮中,口服伊维菌素比局部用药更安全、使用更方便、更便宜、更有效且更经济。

结论

口服伊维菌素是大量人群、不坚持用药者以及结痂性疥疮的首选治疗方法。加拿大默克公司生产的口服伊维菌素商品名为Stromectol 3毫克。非结痂性疥疮的治疗剂量为200微克/千克,与食物一起单次服用。例如,一名70千克的人服用15毫克(5片)。在10 - 14天后进行再次治疗以提高疗效,并可能降低杀疥剂耐药性。

相似文献

1
Scabies: Diagnostic and Therapeutic Update.疥疮:诊断与治疗的最新进展。
J Cutan Med Surg. 2021 Jan-Feb;25(1):95-101. doi: 10.1177/1203475420960446. Epub 2020 Sep 30.
2
Management of scabies.疥疮的管理
Skin Therapy Lett. 2012 Mar;17(3):1-4.
3
Ivermectin for crusted Norwegian scabies induced by use of topical steroids.伊维菌素用于治疗因使用外用类固醇引起的结痂性挪威疥疮。
Arch Dermatol. 1998 Feb;134(2):143-5. doi: 10.1001/archderm.134.2.143.
4
Oral ivermectin treatment in two cases of scabies: effective in crusted scabies induced by corticosteroid but ineffective in nail scabies.两例疥疮的口服伊维菌素治疗:对皮质类固醇诱发的结痂性疥疮有效,但对甲部疥疮无效。
J Dermatol. 2003 May;30(5):411-6. doi: 10.1111/j.1346-8138.2003.tb00408.x.
5
Ivermectin use in scabies.伊维菌素在疥疮治疗中的应用。
Am Fam Physician. 2003 Sep 15;68(6):1089-92.
6
Variable response of crusted scabies to oral ivermectin: report on eight Egyptian patients.结痂性疥疮对口服伊维菌素的可变反应:8例埃及患者的报告
J Eur Acad Dermatol Venereol. 2009 Jul;23(7):793-7. doi: 10.1111/j.1468-3083.2009.03177.x. Epub 2009 Mar 6.
7
Crusted scabies and multiple dosages of ivermectin.结痂性疥疮与多剂量伊维菌素
J Drugs Dermatol. 2013 May;12(5):584-5.
8
[Management of one or several cases of scabies].[疥疮一例或多例的管理]
Arch Pediatr. 2013 Dec;20(12):1358-63. doi: 10.1016/j.arcped.2013.09.027. Epub 2013 Oct 31.
9
Ivermectin for Sarcoptes scabiei hyperinfestation.伊维菌素治疗疥疮重度感染。
Int J Infect Dis. 1998 Jan-Mar;2(3):152-4. doi: 10.1016/s1201-9712(98)90118-7.
10
European guideline for the management of scabies.欧洲疥疮管理指南。
J Eur Acad Dermatol Venereol. 2017 Aug;31(8):1248-1253. doi: 10.1111/jdv.14351. Epub 2017 Jun 22.

引用本文的文献

1
Clinical practice guidelines for the diagnosis and treatment of scabies in Korea: Part 2. Treatment and prevention - a secondary publication.韩国疥疮诊断与治疗临床实践指南:第2部分。治疗与预防——二次发表。
Ewha Med J. 2024 Oct;47(4):e72. doi: 10.12771/emj.2024.e72. Epub 2024 Oct 31.
2
Ivermectin's neuroprotective effects decrease with prolonged use after cerebral ischemia/reperfusion.伊维菌素在脑缺血/再灌注后长期使用时,其神经保护作用会降低。
Metab Brain Dis. 2025 Jun 25;40(6):234. doi: 10.1007/s11011-025-01657-z.
3
The Deadly Itch: A Rare but Fatal Case of Norwegian Scabies.
致命瘙痒:一例罕见的挪威疥疮致死病例
Cureus. 2025 May 1;17(5):e83311. doi: 10.7759/cureus.83311. eCollection 2025 May.
4
Fomite advice for scabies: a review of online resources.疥疮的污染物相关建议:在线资源综述
Skin Health Dis. 2025 Feb 27;5(2):161-164. doi: 10.1093/skinhd/vzae014. eCollection 2025 Apr.
5
Prevalence and determinants of scabies: A global systematic review and meta-analysis.疥疮的患病率及其决定因素:一项全球系统评价与荟萃分析。
Trop Med Int Health. 2024 Dec;29(12):1006-1017. doi: 10.1111/tmi.14058. Epub 2024 Nov 22.
6
Scabies in 604 Patients: A Glimpse into the Disease Burden and Its Associated Mortality in Hong Kong.604例疥疮患者:香港疾病负担及其相关死亡率一瞥。
Trop Med Infect Dis. 2024 Oct 19;9(10):245. doi: 10.3390/tropicalmed9100245.
7
Evaluating the quality and reliability of YouTube videos on scabies in children: A cross-sectional study.评估 YouTube 上有关儿童疥疮的视频质量和可靠性:一项横断面研究。
PLoS One. 2024 Oct 17;19(10):e0310508. doi: 10.1371/journal.pone.0310508. eCollection 2024.
8
Crusted Scabies.结痂性疥疮
Rev Soc Bras Med Trop. 2024 Sep 2;57:e009242024. doi: 10.1590/0037-8682-0199-2024. eCollection 2024.
9
Acute Glomerulonephritis Following Systemic Scabies in Two Brothers.两兄弟全身性疥疮后发生的急性肾小球肾炎
Children (Basel). 2024 Aug 14;11(8):981. doi: 10.3390/children11080981.
10
The hidden scabies: a rare case of atypical Norwegian scabies, case report and literature review.隐匿性疥疮:一例罕见的非典型挪威疥疮病例报告及文献综述
Ital J Pediatr. 2024 Jan 17;50(1):7. doi: 10.1186/s13052-023-01547-z.